NT-0796
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for NT-0796, covering 2024-12-16 to 2026-04-08. Get the full timeline:
Most recent: Clinical Trial Update: Evaluate the Efficacy and Safety of NT-0796 in Participants With Obesity With or Without Type 2 Diabetes Mellitus [Phase 2]